Neuroscience, Neurology, Neuromodulation, Mental Health, Parkinson Disease.
have largely disappointed anyone hoping for new treatments for neurodegnerative and psychiatric disease, and have left patients burdened with these conditions with the highest unmet needs in medicine today. Promising candidates for new neuroscience drugs have repeatedly failed Phase III clinical